Education
About Us
Working with TipRanks
Follow Us
Pharmacielo (TSE:PCLO)
:PCLO
PCLO Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.03 - C$0.23
Previous CloseN/A
Volume2.00K
Average Volume (3M)44.66K
Market Cap
C$6.92M
Enterprise ValueC$34.40M
Total Cash (Recent Filing)C$147.94K
Total Debt (Recent Filing)C$20.52M
Price to Earnings (P/E)―
Beta-0.01
Next Earnings
Dec 08, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding187,828,800
10 Day Avg. Volume7,461
30 Day Avg. Volume44,665
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PharmaCielo News
PCLO FAQ
What was Pharmacielo’s price range in the past 12 months?
Pharmacielo lowest stock price was C$0.03 and its highest was C$0.23 in the past 12 months.
What is Pharmacielo’s market cap?
Pharmacielo’s market cap is C$6.92M.
When is Pharmacielo’s upcoming earnings report date?
Pharmacielo’s upcoming earnings report date is Dec 08, 2025 which is in 113 days.
How were Pharmacielo’s earnings last quarter?
Currently, no data Available
Is Pharmacielo overvalued?
According to Wall Street analysts Pharmacielo’s price is currently Overvalued.
Does Pharmacielo pay dividends?
Pharmacielo does not currently pay dividends.
What is Pharmacielo’s EPS estimate?
Pharmacielo’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharmacielo have?
Pharmacielo has 187,828,800 shares outstanding.
What happened to Pharmacielo’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pharmacielo?
Currently, no hedge funds are holding shares in TSE:PCLO
Company Description
Pharmacielo
PharmaCielo Ltd. (PCLO) is a Canadian company focused on the production and supply of high-quality cannabis extracts and related products. Operating primarily in the pharmaceutical and wellness sectors, PharmaCielo leverages its extensive Colombian operations, which include cultivation and processing facilities, to produce a range of cannabinoid-derived products. The company is committed to becoming a leading global supplier of naturally grown cannabis products, emphasizing sustainability and quality in its operations.
Technical Analysis
Ownership Overview
7.76% Insiders
4.39%
Mutual Funds
<0.01% Other Institutional Investors
92.05% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---